206 related articles for article (PubMed ID: 34308752)
1. miR-148a-3p suppresses the progression of acute myeloid leukemia via targeting cyclin-dependent kinase 6 (CDK6).
Zhou H; Jia X; Yang F; Shi P
Bioengineered; 2021 Dec; 12(1):4508-4519. PubMed ID: 34308752
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin regulates the proliferation, apoptosis, migration and invasion of human acute myeloid leukemia cells via miR-19a-3p/HIF-1α axis.
Tian H; Qiang T; Wang J; Ji L; Li B
Bioengineered; 2021 Dec; 12(2):11898-11908. PubMed ID: 34895042
[TBL] [Abstract][Full Text] [Related]
3. [Proliferation, migration and apoptosis of acute myeloid leukemia cells regulated by mir-23a-3p targeting SMC1A and the mechanism].
Zhang YS; Wang MY; Zhang WL; Tang CH
Zhonghua Zhong Liu Za Zhi; 2019 Oct; 41(10):753-759. PubMed ID: 31648497
[No Abstract] [Full Text] [Related]
4. LncRNA KCNQ1OT1 contributes to the progression and chemoresistance in acute myeloid leukemia by modulating Tspan3 through suppressing miR-193a-3p.
Sun H; Sun Y; Chen Q; Xu Z
Life Sci; 2020 Jan; 241():117161. PubMed ID: 31837329
[TBL] [Abstract][Full Text] [Related]
5. miR-342-3p Suppresses glioblastoma development via targeting CDK6.
Yao J; Dai Y; Liu Z; Hu W; Wan Y
Acta Biochim Pol; 2022 May; 69(2):393-397. PubMed ID: 35616621
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-582-3p negatively regulates cell proliferation and cell cycle progression in acute myeloid leukemia by targeting cyclin B2.
Li H; Tian X; Wang P; Huang M; Xu R; Nie T
Cell Mol Biol Lett; 2019; 24():66. PubMed ID: 31844417
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of miR-504-3p is associated with favorable prognosis of acute myeloid leukemia and may serve as a tumor suppressor by targeting MTHFD2.
Li SM; Zhao YQ; Hao YL; Liang YY
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1203-1213. PubMed ID: 30779090
[TBL] [Abstract][Full Text] [Related]
8. Tumor-suppressing effects of miR-381-3p in pediatric acute myeloid leukemia via ROCK1 downregulation.
Ye Q; Ying Q; Dai Q; Liao C; Xiao G
Funct Integr Genomics; 2023 Jan; 23(1):43. PubMed ID: 36658407
[TBL] [Abstract][Full Text] [Related]
9. miR-186 Represses Proliferation, Migration, Invasion, and EMT of Hepatocellular Carcinoma via Directly Targeting CDK6.
Lu J; Zhao Z; Ma Y
Oncol Res; 2020 Dec; 28(5):509-518. PubMed ID: 32698940
[TBL] [Abstract][Full Text] [Related]
10. Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer.
Li J; Ying Y; Xie H; Jin K; Yan H; Wang S; Xu M; Xu X; Wang X; Yang K; Zheng X; Xie L
FASEB J; 2019 Jan; 33(1):1374-1388. PubMed ID: 30138038
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA UCA1 modulates cell proliferation and apoptosis by regulating miR-296-3p/Myc axis in acute myeloid leukemia.
Li J; Wang M; Chen X
Cell Cycle; 2020 Jun; 19(12):1454-1465. PubMed ID: 32286143
[TBL] [Abstract][Full Text] [Related]
12. miR-148a-3p inhibits the proliferation and migration of bladder cancer
Xu C; Zhou G; Sun Z; Zhang Z; Zhao H; Jiang X
PeerJ; 2022; 10():e12724. PubMed ID: 35127282
[TBL] [Abstract][Full Text] [Related]
13. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
Shi J; Tan S; Song L; Song L; Wang Y
Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
[TBL] [Abstract][Full Text] [Related]
14. Matrine regulates miR-495-3p/miR-543/PDK1 axis to repress the progression of acute myeloid leukemia via the Wnt/β-catenin pathway.
Lei Y; Li X; Zhu L
Chem Biol Drug Des; 2024 Jan; 103(1):e14441. PubMed ID: 38230785
[TBL] [Abstract][Full Text] [Related]
15. The hsa-miR-214-3p/ATGL axis regulates aberrant lipolysis to promote acute myeloid leukemia progression via PPARα in vitro.
Li Y; Yuan S; Wu W; Zhou J; Zhang P; Li D; Zhang Y; Lou S
Biochem Biophys Res Commun; 2022 Jun; 608():73-81. PubMed ID: 35395550
[TBL] [Abstract][Full Text] [Related]
16. LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro.
Tang Y; Yang P; Zhu Y; Su Y
Thorac Cancer; 2020 Jan; 11(1):82-94. PubMed ID: 31742924
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-15 suppresses viability, migration and invasion of the human MG-63 osteosarcoma cells via inhibition of cyclin dependent kinase 6 (CDK6).
Shen Z; Wang C; Liu B; Du J; Li Z; Zhao J
Acta Biochim Pol; 2022 Oct; 69(4):761-766. PubMed ID: 36272153
[TBL] [Abstract][Full Text] [Related]
18. miR-29b-3p suppresses the malignant biological behaviors of AML cells via inhibiting NF-κB and JAK/STAT signaling pathways by targeting HuR.
Tang YJ; Wu W; Chen QQ; Liu SH; Zheng ZY; Cui ZL; Xu JP; Xue Y; Lin DH
BMC Cancer; 2022 Aug; 22(1):909. PubMed ID: 35986311
[TBL] [Abstract][Full Text] [Related]
19. miR-148a-3p Suppresses the Proliferation and Invasion of Esophageal Cancer by Targeting DNMT1.
Wang Y; Hu Y; Guo J; Wang L
Genet Test Mol Biomarkers; 2019 Feb; 23(2):98-104. PubMed ID: 30735457
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of miR-124-3p by Liver X Receptor Inhibits the Growth of Hepatocellular Carcinoma Cells Via Suppressing Cyclin D1 and CDK6.
Zhong D; Lyu X; Fu X; Xie P; Liu M; He F; Huang G
Technol Cancer Res Treat; 2020; 19():1533033820967473. PubMed ID: 33073697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
